A systematic review and network meta-analysis of interventions to preserve insulin-secreting beta cell function in people newly diagnosed with type 1 diabetes: results from randomised controlled trials of immunomodulatory therapies

Abstract Background Type 1 diabetes is characterised by the immune-mediated destruction of pancreatic beta cells. We aimed to determine the effectiveness of immunotherapies for preserving residual beta cell function in newly diagnosed (stage 3) type 1 diabetes. Methods Searches were carried out in M...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Sophie E. Beese, Malcolm J. Price, Claire Tomlinson, Pawana Sharma, Isobel M. Harris, Ada Adriano, Lauren M. Quinn, Ritu Gada, Thomas J. Horgan, Fiona Maggs, Martin Burrows, Krishnarajah Nirantharakumar, G. Neil Thomas, Robert C. Andrews, David J. Moore, Parth Narendran
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2025-07-01
Sarja:	BMC Medicine
Aiheet:	Systematic review Network meta-analysis Type 1 diabetes Beta cells
Linkit:	https://doi.org/10.1186/s12916-025-04201-z
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!